Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1997;29:969-975

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minami, N.
Right arrow Articles by Abe, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minami, N.
Right arrow Articles by Abe, K.

(Hypertension. 1997;29:969-975.)
© 1997 American Heart Association, Inc.


Articles

Role of Nitric Oxide in the Development of Vascular {alpha}1-Adrenoreceptor Desensitization and Pressure Diuresis in Conscious Rats

Naoyoshi Minami; Yutaka Imai; Hisamitu Nishiyama; ; Keishi Abe

From The Second Department of Internal Medicine, Tohoku University School of Medicine, Sendai, Japan.

Correspondence to Naoyoshi Minami, MD, The Second Department of Internal Medicine, Tohoku University School of Medicine, 1-1 Seiryou-cho, Aoba-ku, Sendai 980, Japan.

Abstract We evaluated whether a minor impairment of the L-arginine–nitric oxide pathway would affect the desensitization of vascular {alpha}-adrenoreceptor and pressure diuresis induced by prolonged intravenous infusion of phenylephrine (an {alpha}-adrenoreceptor agonist) in conscious Wistar-Kyoto rats. We examined dose-pressor–response curves to phenylephrine after an intravenous infusion of phenylephrine (2.5 µg·kg-1·min-1) or saline for 9 hours with and without concomitant infusion of N{omega}-L-arginine methyl ester (L-NAME) given to partially inhibit the L-arginine–nitric oxide pathway. In addition, to evaluate the effect of plasma volume loss on the pressor response to phenylephrine, we evaluated the dose-pressor–response curves to phenylephrine after intravenous injection of furosemide (5 mg/kg) or infusion of phenylephrine (5 µg·kg-1·min-1) for 9 hours. The renin-angiotensin, vasopressin and autonomic nervous systems were blocked before the examination of dose-pressor responses. Prolonged infusion of phenylephrine (2.5 µg·kg-1·min-1) shifted the dose pressor–response curve to this agent rightward, with significantly increased log ED50 (the dose needed to reach 50% of the maximal response) to a similar extent in both L-NAME–treated (0.51±0.05 versus 0.93±0.07 µg/kg) and –untreated (0.79±0.06 versus 1.08±0.03 µg/kg) rats. The log ED50 value after phenylephrine infusion (5 µg·kg-1·min-1) was significantly higher than that after furosemide injection (1.28±0.06 versus 1.02±0.01 µg/kg, respectively, P<.01), although the two treatments induced a similar loss of plasma volume. The slope in the linear relationship between the average change in mean arterial pressure during the 9-hour infusion period and the rate of urine excretion was significantly depressed in L-NAME–treated versus control rats (L-NAME: 0.057 mL·kg-1·h-1·mm Hg-1, control: 0.146 mL·kg-1·h-1·mm Hg-1, P<.05). In conclusion, a minor impairment of the L-arginine–nitric oxide pathway does not appear to interfere with the desensitization of vascular {alpha}-adrenoreceptor but does inhibit the pressure-diuresis response in conscious normotensive rats.


Key Words: nitric oxide • receptors, adrenergic alpha • desensitization, adrenergic • diuresis • rats